Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
440.6 USD | +0.72% | +5.17% | +8.29% |
15/05 | Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director | CI |
14/05 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.29% | 22.28B | |
-5.52% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B | |
-22.94% | 8.45B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated - Special Call